T1	Participants 33 80	relapsing-remitting multiple sclerosis (SELECT)
T2	Participants 426 477	patients with relapsing-remitting multiple sclerosi
T3	Participants 551 653	76 centres in the Czech Republic, Germany, Hungary, India, Poland, Russia, Ukraine, Turkey, and the UK
T4	Participants 694 763	Patients aged 18-55 years with relapsing-remitting multiple sclerosis
T5	Participants 1293 1305	204 patients
T6	Participants 1340 1343	208
T7	Participants 2526 2553	relapsing-remitting disease
